Analyzing Boston Scientific’s Financial Performance
In Q1 2018, Boston Scientific (BSX) generated sales of $2.4 billion compared to $2.2 billion in Q1 2017. The company’s cost of goods sold increased from $650 million in Q1 2017 to $672 million in Q1 2018. The increase was due to the positive impact of cost reductions from Boston Scientific’s process improvement programs and restructuring programs.